Ischemic Attack, Transient Clinical Trial
Official title:
Cognitive and Physical Functions in Patients With TIA. A Randomized Controlled Trial of Physical Activity on Prescription up to One Year After the Event
The purpose of this study is to determine whether Physical Activation on Prescription can
help patients with TIA to become more physically active.
One group will receives Physical Activation on Prescription (PaP)and the other group will
receives usual care.
And to identify if persons with TIA presents with cognitive impairments.
Transient ischemic attack (TIA) is a transient episode of neurologic dysfunction caused by ischemia, i.e. loss of blood flow. The symptoms of a TIA typically resolve within 24 hours. Attacks lasting more than 30 minutes are unusual. TIAs and strokes present with the same symptoms such as sudden weakness, numbness, sudden dimming or loss of vision, aphasia, slurred speech, facial palsy and mental impairments. Subtle problems with cognitive functions and fatigue may not always be addressed before discharge. However, even subtle mental impairments are important to identify, given the problems they might pose. ;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02141932 -
Pocket-size Cardiovascular Ultrasound in Stroke
|
N/A | |
| Recruiting |
NCT02662751 -
Performing a Low-dose, Whole-body Angiography as the First Element of an Imaging Assessment Following Stroke / TIA
|
N/A | |
| Completed |
NCT02038725 -
MIDNOR-TIA - a Study of 600 Patients With Transient Ischemic Attack
|
||
| Completed |
NCT01528462 -
Sleep Disorders Managed and Assessed Rapidly in Transient Ischemic Attack (TIA) and In Early Stroke
|
||
| Withdrawn |
NCT00069069 -
E-Selectin Nasal Instillation to Prevent Secondary Stroke
|
Phase 1 | |
| Recruiting |
NCT02701998 -
The Stroke and Exercise Program
|
N/A | |
| Completed |
NCT02450760 -
Connected Health Blood Pressure Monitoring In Stroke and TIA Patients
|
N/A | |
| Completed |
NCT02089074 -
Systematic Follow up of Drug Treatment by Pharmacists in Secondary Prevention After Transient Ischemic Attack
|
N/A | |
| Completed |
NCT00250380 -
The Study on Profile and Genetic Factors of Aspirin Resistance (ProGEAR Study)
|
Phase 4 | |
| Terminated |
NCT00991029 -
Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
|
Phase 3 | |
| Recruiting |
NCT06407154 -
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study, 2nd Wave
|
||
| Completed |
NCT00061022 -
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
|
Phase 3 | |
| Completed |
NCT02415855 -
Canadian Pradaxa Acute Stroke Safety Study
|
||
| Completed |
NCT02799511 -
Biomarkers for the Diagnosis of Transient Ischemic Attack
|
N/A | |
| Completed |
NCT00514800 -
Home Blood Pressure Monitoring Trial
|
Phase 3 | |
| Recruiting |
NCT00553241 -
Short-Term Prognosis Evaluation of Transient Ischemic Attack Patients Using ABCD2 Score
|
N/A | |
| Active, not recruiting |
NCT00201461 -
Evaluation of the STARFlex® Septal Closure System in Patients With a Stroke or TIA Due to the Possible Passage of a Clot of Unknown Origin Through a Patent Foramen Ovale (PFO)
|
Phase 2/Phase 3 | |
| Completed |
NCT00119626 -
Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke
|
Phase 3 | |
| Terminated |
NCT05961163 -
Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures: an Observational Study
|
||
| Completed |
NCT00590980 -
Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS)
|
N/A |